OpenEvidence closed a $250 million funding round, doubling its valuation to $12 billion as its ad-supported AI tool gains traction with US physicians.
The free download is not a trial or evaluation version. It includes the SDA runtime, Studio, and API with no time limits, capacity restrictions, or disabled capabilities. Software-defined automation ...
Flexxbotics, the autonomous manufacturing platform leader, announced the release of its software-defined automation as a free ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する